Parkinson's Disease Genetics and Pathophysiology
- PMID: 34236893
- DOI: 10.1146/annurev-neuro-100720-034518
Parkinson's Disease Genetics and Pathophysiology
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by degeneration of the substantia nigra pars compacta and by accumulation of α-synuclein in Lewy bodies. PD is caused by a combination of environmental factors and genetic variants. These variants range from highly penetrant Mendelian alleles to alleles that only modestly increase disease risk. Here, we review what is known about the genetics of PD. We also describe how PD genetics have solidified the role of endosomal, lysosomal, and mitochondrial dysfunction in PD pathophysiology. Finally, we highlight how all three pathways are affected by α-synuclein and how this knowledge may be harnessed for the development of disease-modifying therapeutics.
Keywords: GBA; LRRK2; Parkinson's disease; genetics; lysosome; mitochondria; vesicular trafficking; α-synuclein.
Similar articles
-
Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.Adv Neurobiol. 2017;14:209-226. doi: 10.1007/978-3-319-49969-7_11. Adv Neurobiol. 2017. PMID: 28353286 Review.
-
Current trends in basic research on Parkinson's disease: from mitochondria, lysosome to α-synuclein.J Neural Transm (Vienna). 2024 Jun;131(6):663-674. doi: 10.1007/s00702-024-02774-2. Epub 2024 Apr 13. J Neural Transm (Vienna). 2024. PMID: 38613675 Free PMC article. Review.
-
The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.Brain. 2017 Apr 1;140(4):878-886. doi: 10.1093/brain/aww227. Brain. 2017. PMID: 27585855
-
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Free Radic Biol Med. 2013. PMID: 23743292 Review.
-
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.Int J Mol Sci. 2019 Oct 25;20(21):5312. doi: 10.3390/ijms20215312. Int J Mol Sci. 2019. PMID: 31731450 Free PMC article. Review.
Cited by
-
Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.Int J Mol Sci. 2024 Sep 23;25(18):10187. doi: 10.3390/ijms251810187. Int J Mol Sci. 2024. PMID: 39337671 Free PMC article. Review.
-
The cervical lymph node contributes to peripheral inflammation related to Parkinson's disease.J Neuroinflammation. 2023 Apr 10;20(1):93. doi: 10.1186/s12974-023-02770-5. J Neuroinflammation. 2023. PMID: 37038192 Free PMC article.
-
Multi-functional role of apolipoprotein E in neurodegenerative diseases.Front Aging Neurosci. 2025 Jan 29;17:1535280. doi: 10.3389/fnagi.2025.1535280. eCollection 2025. Front Aging Neurosci. 2025. PMID: 39944166 Free PMC article. Review.
-
Dopamine-conjugated extracellular vesicles induce autophagy in Parkinson's disease.J Extracell Vesicles. 2024 Dec;13(12):e70018. doi: 10.1002/jev2.70018. J Extracell Vesicles. 2024. PMID: 39641313 Free PMC article.
-
Patients' experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa/foscarbidopa in Parkinson's disease.J Neurol. 2025 May 22;272(6):416. doi: 10.1007/s00415-025-13123-y. J Neurol. 2025. PMID: 40402298 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous